Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Cardiol Therapeutics Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 35 | 1 | 41 | +7 |
| Shares | 6.55M | 80.0K | 5.39M | −1.08M (−16.7%) |
| Value | $11.7M | $194.4K | $10.8M | −$718.0K (−6.2%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Cardiol Therapeutics Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Knoll Capital Management, LLC | 100,000 | $202.0K | 0.14% |
| UBS Asset Management Americas Inc | 55,000 | $111.1K | 0.00% |
| Foundations Investment Advisors, LLC | 48,000 | $97.0K | 0.00% |
| Arrowstreet Capital, Limited Partnership | 29,294 | $58.0K | 0.00% |
| Morgan Stanley | 27,300 | $55.1K | 0.00% |
| Baader Bank INC | 29,028 | $34.4K | 0.00% |
| Atria Investments LLC | 11,165 | $22.6K | 0.00% |
| Verition Fund Management LLC | 11,109 | $22.4K | 0.00% |
| CIBC Private Wealth Group, LLC | 8,000 | $15.0K | 0.00% |
| Hartford Financial Management Inc. | 4,000 | $8.08K | 0.00% |
| Painted Porch Advisors LLC | 500 | $1.01K | 0.00% |
| Stone House Investment Management, LLC | 50 | $101 | 0.00% |
Sold out (5)
Institutions that held Cardiol Therapeutics Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Two Sigma Advisers, LP | 16,500 | $29.9K |
| Two Sigma Securities, LLC | 14,681 | $26.6K |
| TownSquare Capital, LLC | 12,661 | $22.9K |
| Raymond James & Associates | 11,154 | $20.2K |
| City State Bank | 825 | $1.00K |
Not filed for Q2 2024 yet (1)
Institutions that held Cardiol Therapeutics Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 80,000 | $194.4K |